How chronic viral infections affect the immune system in organ transplant patients

Immune control of chronic viral infection in solid organ transplantation

NIH-funded research Veterans Admin Palo Alto Health Care Sys · NIH-10928049

This study is looking at how a virus called Cytomegalovirus (CMV) affects the immune system of people who have received organ transplants, especially how it might make their immune cells age faster and impact their ability to fight infections and respond to vaccines, with the goal of finding better ways to support their immune health.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVeterans Admin Palo Alto Health Care Sys NIH-funded
Lab location1 site (Palo Alto, United States)
Project IDNIH-10928049 on NIH RePORTER

What this research studies

This research investigates how latent Cytomegalovirus (CMV) affects the immune response in patients who have undergone solid organ transplantation. It focuses on understanding the accelerated aging of immune cells, particularly T and B cells, in these patients and how this impacts their ability to respond to infections and vaccinations. By studying a network of transplant centers, the research aims to uncover the long-term effects of CMV on immune function post-transplant. The findings could lead to improved strategies for managing immune health in transplant recipients.

Who could benefit from this research

Good fit: Ideal candidates for this research are adults who have received solid organ transplants and are latently infected with Cytomegalovirus.

Not a fit: Patients who have not undergone organ transplantation or are not infected with Cytomegalovirus may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could enhance the immune responses of organ transplant patients, leading to better health outcomes and reduced complications from infections.

How similar studies have performed: Previous research has shown that understanding the immune response in transplant patients can lead to significant advancements in patient care, indicating that this approach has potential for success.

Where this research is happening

Palo Alto, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.